Research & Education

NSCLC: Management of Brain Metastases

Wednesday, April 19, 2017 at 9:00PM EDT - Recording Available



Corey J. Langer MD, FACP
Director of Thoracic Oncology
Abramson Cancer Center
Professor of Medicine
University of Pennsylvania

Ramaswamy Govindan, MD - Program Chair
Co-Director, Section of Medical Oncology
Professor of Medicine
Anheuser-Busch Endowed Chair in Medical Oncology
Director, Section of Oncology
Washington University School of Medicine

Name of Reviewer(s): 


Laurie Gaspar, MD –Nothing to Disclose

Name of Planner(s): 


Pia Hirsch-Nothing to Disclose      Carlos Ferreira-Nothing to Disclose


Name of Activity: 


NSCLC: Management of Brain Metastases

Date of Activity:




COI Resolution: Ensure a balanced discussion of alternative. Do not use trade names. Do not refer to company names or logos. Do not recommend therapies.

“All planning committee members’, reviewers, planners and faculty et al. identified conflicts of interest pertaining to this activity were resolved prior to the activity.”

Chair: Ramaswamy Govindan, MD

Honoraria with the following: ABBVIE, ARIAD, AZ, BAXALTA, BMS, MERCK and ROCHE.


Speaker: Corey J. Langer, MD

Speakers/Advisory Board, Consulting and Research Grant from: BMS, Merck, AZ, Ariad (Takeda), Genentech/Roche, Lilly, Helsinn, Pfizer, Clovis, BI - Advisory Board/Consultant

Type of Activity:

 Live Course

  Internet Live Course (Webinar)XXXX

 Internet Enduring Material

Are there Commercial Supporters for this activity?


If yes, please list:

In this program, we will cover:

  • the incidence and epidemiology of brain metastases in NSCLC;
  • its prognostic implications;
  • current management, including surgical, radiation and systemic options.

After viewing this program attendees will be able to:

  • delineate the incidence, epidemiology and prognostic implications of brain metastases in advanced NSCLC;
  • identify the potential role of craniotomy and surgical resection in the management of CNS metastases;
  • differentiate the indications for whole brain vs stereotactic XRT in the management of brain metastases and identify the literature that supports these approaches;
  • quantify the risks of brain irradiation, either alone or in combination with systemic treatment.

Following the presentation, there will be ample time for discussion and a question/answer session. Attendees will be able to submit questions and comments to Dr. Langer via internet chat.

This CME live webinar series is designed to meet the educational needs of healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.  

In order to receive CME credit, attendees must fill out a program evaluation.

Financial/Commercial and Conflicts of Interest Disclosures

IASLC Financial/Commercial Relationships and Conflicts of Interest Policy

IASLC Honoraria Policy

IASLC Commercial Support Agreement (LOA)


Please complete the evaluation link provided to you after the activity. The certificate of credit will be ready for you to print or save for your records.

IASLC Lung Cancer Grand Rounds webinars will continue throughout 2017. The goal is to hold one program monthly. Participants who complete a pre-and post-test along with an evaluation will receive 1 AMA PRA Category 1 CreditTM for each completed webinar.

Use the Time Zone Converter